Cargando…
Bispecific antibodies come to the aid of cancer immunotherapy
Three collaborative studies published by the groups of Vogelstein, Gabelli, and Zhou report the development of specially designed bispecific antibodies that may help in overcoming the limitations of current immunotherapies. The bispecific antibodies have been designed to couple cells harboring HLA‐p...
Autores principales: | Amelio, Ivano, Melino, Gerry, Levine, Arnold J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8253090/ https://www.ncbi.nlm.nih.gov/pubmed/33942515 http://dx.doi.org/10.1002/1878-0261.12977 |
Ejemplares similares
-
Exploiting tumour addiction with a serine and glycine-free diet
por: Amelio, Ivano, et al.
Publicado: (2017) -
Recent advances in cancer immunotherapy
por: Sun, Qiang, et al.
Publicado: (2021) -
The “Sharp” blade against HIF-mediated metastasis
por: Amelio, Ivano, et al.
Publicado: (2012) -
Damage limitation
por: Amelio, Ivano, et al.
Publicado: (2016) -
Context is everything: extrinsic signalling and gain-of-function p53 mutants
por: Amelio, Ivano, et al.
Publicado: (2020)